Menu

Ebola Update: Funding, Vaccines, and More Deaths in DRC

A total of 27 people have died since April, but new funds and the deployment of an experimental vaccine are expected to help contain the virus.

May 23, 2018
Catherine Offord

World Health Organization workers deployed medical kits in response to reports of Ebola cases in DRC in 2017.FLICKR, MONUSCOThe US government has committed another $7 million in funds to fighting Ebola in Democratic Republic of Congo, bringing its total contribution to $8 million, according to a press statement yesterday (May 22) by US Secretary of Health and Human Services, Alex Azar. The announcement comes amid reports of another two deaths from the virus in an outbreak that has killed 27 people since April, prompting the first deployment of an experimental vaccine in the region this week.

“The risk of spreading within the country and to neighboring nations remains real,” Fatoumata Nafo-Traoré of the International Federation of Red Cross and Red Crescent Societies tells Reuters. “One of the lessons we learned in our response to other deadly Ebola outbreaks is that complacency can kill.”

See “Two Ebola Cases Confirmed in Democratic Republic of Congo

Health authorities were widely criticized for failing to respond more quickly to the outbreak of Ebola in West Africa, which claimed more than 11,000 lives between 2013 and 2016. A much faster response to news of eight confirmed cases and four deaths in Democratic Republic of Congo (DRC) early last year resulted in the World Health Organization (WHO) declaring that outbreak over within a few months.

See “Officials Declare Congo’s Ebola Outbreak Over

Cases began reappearing in DRC in the rural town of Bikoro earlier this year. The current outbreak has now spread to Mbandaka, a well-connected port city with a population of around 1.2 million. This time, however, health workers have access to an experimental vaccine, Merck’s rVSV-ZEBOV, which saw its first deployment in DRC on Monday (May 21). “I think it’s important that we have something to offer now and something that hopefully helps to contain this terrible disease,” the vaccine’s designer Heinz Feldmann tells STAT News.

See “Experimental Ebola Vaccine to be Used in DRC Outbreak

Merck has supplied the WHO with 8,640 doses of the vaccine—which has completed Phase 3 trials but has yet to receive regulatory approval—with another 8,000 on their way, Reuters reports. Meanwhile, the WHO is also consulting various health organizations about the use of additional experimental drugs, including antibody and antiviral treatments, for people who have already been infected, Nature reports.

“If we’re lucky and the disease doesn’t spread, the outbreak will be quickly resolved and we will have to use few experimental products,” Annick Antierens of Médecins Sans Frontières tells Nature. “But if we’re unlucky we’ll need to use them.”

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Enabling Genomics-Guided Precision Medicine

Enabling Genomics-Guided Precision Medicine

Download this eBook from Qiagen to learn more about the promise of precision medicine and how QCITM Interpret can help deliver better care with better knowledge.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!